# A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

> clinical trial · VERIFIED · 2026-06-25

Status: NOT_YET_RECRUITING · Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Condition: HNSCC

- Company: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07668154

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.